Value-Based Contracting: CMS Final Rule Leaves ‘Multiple Best Price’ Questions Unresolved

Implementation of ‘multiple best price’ reporting approach to facilitate value-based payment arrangements postponed until 2022 to allow time for further guidance to be developed, but new definition of VBP arrangements is effective in March.

CMS To Address 'Multiple Best Price' Questions With Operational Guidance In 2021

The Centers for Medicare and Medicaid Services final rule addressing Medicaid value-based purchasing arrangements for drugs won’t move the needle much in the near term on advancing innovative purchasing arrangements for cell and gene therapy, an issue of increasing concern to Medicaid programs and other payers.

Published in the 31 December Federal Register, the final rule’s provisions aimed at supporting value-based payment arrangements are very...

More from Market Access

More from Pink Sheet